Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Lucentis 10 mg/ml solution for injection

Active Ingredient:
Company:  
Novartis Pharmaceuticals UK Ltd See contact details
ATC code: 
S01LA04
{info_black}
About Medicine
Audio Guides to Lucentis - Click on the PLAY button to listen, or right click to save the audio file. To view or download a text version see the 'Risk Materials' tab.

Lucentis ( ranibizumab) - Patient Booklet (AMD) - Audio Version
This guide was created to help you better understand LUCENTIS® when used for the treatment of neovascular (wet) age-related macular degeneration (AMD)



Lucentis (ranibizumab) - Patient booklet (RVO) - Audio Version
This guide was created to help you better understand LUCENTIS® when used for the treatment of visual impairment due to retinal vein occlusion (RVO)



Lucentis (ranibizumab) - Patient booklet (CNV) - Audio Version
This guide was created to help you better understand LUCENTIS® when used for the treatment of visual impairment due to choroidal neovascularization (CNV).



Lucentis (ranibizumab) - Patient booklet (PDR/DMO)- Audio Version
This guide was created to help you better understand LUCENTIS® when used for the treatment of Diabetic macular oedema (DMO) and/or Proliferative diabetic retinopathy.



Novartis Pharmaceuticals UK Ltd
Company image
Address
2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ
Telephone
+44 (0)1276 692 255
Medical Information Direct Line
+44 (0)1276 698 370
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)845 741 9442